» Articles » PMID: 11847516

Proteinase Activity Regulation by Glycosaminoglycans

Overview
Date 2002 Feb 16
PMID 11847516
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

There are few reports concerning the biological role and the mechanisms of interaction between proteinases and carbohydrates other than those involved in clotting. It has been shown that the interplay of enzymes and glycosaminoglycans is able to modulate the activity of different proteases and also to affect their structures. From the large number of proteases belonging to the well-known protease families and also the variety of carbohydrates described as widely distributed, only few events have been analyzed more deeply. The term "family" is used to describe a group of proteases in which every member shows an evolutionary relationship to at least one other protease. This relationship may be evident throughout the entire sequence, or at least in that part of the sequence responsible for catalytic activity. The majority of proteases belong to the serine, cysteine, aspartic or metalloprotease families. By considering the existing limited proteolysis process, in addition to the initial idea that the proteinases participate only in digestive processes, it is possible to conclude that the function of the enzymes is strictly limited to the cleavage of intended substrates since the destruction of functional proteins would result in normal tissue damage. In addition, the location as well as the eventual regulation of protease activity promoted by glycosaminoglycans can play an essential role in the development of several physiopathological conditions.

Citing Articles

Thrombin-derived C-terminal peptides bind and form aggregates with sulfated glycosaminoglycans.

Petruk G, Petrlova J, Samsudin F, Bond P, Schmidtchen A Heliyon. 2024; 10(16):e35703.

PMID: 39229523 PMC: 11369470. DOI: 10.1016/j.heliyon.2024.e35703.


Mode of Action of Antimicrobial Potential Protease SH21 Derived from .

Tarek H, Cho S, Nam K, Lee J, Lee S, Yoo J Int J Mol Sci. 2024; 25(13).

PMID: 39000152 PMC: 11241523. DOI: 10.3390/ijms25137046.


Atypical enteropathogenic Escherichia coli secretes plasmid encoded toxin.

Ruiz R, Melo K, Rossato S, Barbosa C, Correa L, Elias W Biomed Res Int. 2014; 2014:896235.

PMID: 24949475 PMC: 4037613. DOI: 10.1155/2014/896235.


Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Mannello F, Raffetto J Am J Transl Res. 2011; 3(2):149-58.

PMID: 21416057 PMC: 3056561.